Is a complete DARE research report available?

No complete published report is available for Daré Bioscience, Inc. (DARE) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Daré Bioscience, Inc. (DARE)

NASDAQ: DARE · USD

$1.22

-0.02 (-1.6%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-08-02 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first DARE analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	18.3M
Revenue (ttm)	1.2M
Net income (ttm)	-12M
EPS (ttm)	-$0.95
Shares out	15M
Volume	73,269
Beta	1.02
Price target	$9.67	+692.6%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.2M
Net income (ttm): -12M
EPS (ttm): -$0.95
Market cap: 18.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.5B	36.6x	5.7x	96.6%	+47.5%	-39.5%	Strong Buy
ARGX	argenx SE	53.6B	31.3x	10.1x	50.6%	+58.8%	+42.6%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All DARE indicators

Market & fundamental data

Available fields

207

Groups with data

Currency

USD

Showing 207 of 207 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001401914
Company name	Daré Bioscience, Inc.
Country	United States
Country code	US
Cusip	23666P200
Employees	24
Employees Change	1%
Employees Change Percent	4.35
Enterprise value	$6.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US23666P2002
Last refreshed	2026-08-02
Market cap	$18.3M
Market cap category	Nano-Cap
Price	$1.22
Price currency	USD
Rev Per Employee	48,217.54x
Sector	Healthcare
Sector PE	43.27
Sector PE Fwd	23.33
Sic	2834
Symbol	DARE
Website	https://darebioscience.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-65.78%
EV Sales Forward	2.18x
EV/Sales	6x
FCF yield	-55.62%
P/B ratio	24.21x
P/S ratio	15.79x
PS Forward	5.75x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-1,034.38%
EBITDA Margin	-858.88%
Gross margin	194.95%
Gross Profit	$2.3M
Gross Profit Growth	107.03%
Net Income	$-12M
Net Income Growth Quarters	3%
Net Income Growth Years	0%
Pretax Margin	-1,038.77%
Profit Per Employee	$-500,869
ROA	-32.21
Roa5y	-54.82
ROCE	-178.4
ROIC	-776.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-48.87%
Cagr3y	-48.54%
Cagr5y	-41.94%
EPS Growth Quarters	3
EPS Growth Years	0
Revenue Growth	4,366.48x
Revenue Growth Q	499.58x
Revenue Growth Quarters	2x
Revenue Growth Years	1x
Revenue Growth3 Y	-51.27x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.05
Assets	$27.8M
Cash	$18.5M
Current Assets	$21.7M
Current Liabilities	$21.1M
Debt	$7.2M
Debt Equity	$9.78
Equity	$734,451
Liabilities	$27.1M
Long Term Assets	$6.2M
Long Term Liabilities	$6M
Net Cash	$11.3M
Net Cash By Market Cap	$62.03
Net Cash Growth	67.77%
Net Debt Equity	$-15.44
Tangible Book Value	$733,795
Tangible Book Value Per Share	$0.05
WACC	7.1

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.03
Net Working Capital	$-16.8M
Quick ratio	0.89
Working Capital	$540,124
Working Capital Turnover	$-0.26

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-46.86%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-48.85%
200-day SMA	1.94
3Y total return	-86.38%
50-day SMA	1.93
50-day SMA vs 200-day SMA	50under200
5Y total return	-93.4%
All Time High	79.47
All Time High Change	-98.46%
All Time High Date	2017-07-20
All Time Low	1.13
All Time Low Change	7.96%
All Time Low Date	2026-07-30
ATR	0.13
Beta	1.02
Beta1y	3.46
Beta2y	1.4
Ch YTD	-36.79
High	1.27
High52	3.78
High52 Date	2026-05-05
High52ch	-67.72%
Low	1.21
Low52	1.13
Low52 Date	2026-07-30
Low52ch	7.97%
Ma50ch	-36.75%
Premarket Change Percent	2.97
Premarket Price	$1.28
Premarket Volume	1,950
Price vs 200-day SMA	-37.11%
RSI	28.21
RSI Monthly	32.37
RSI Weekly	38.52
Sharpe ratio	-0.26x
Sortino ratio	-0.35
Total Return	-46.86%
Tr YTD	-36.79
Tr1m	-42.18%
Tr1w	-4.69%
Tr3m	-46.49%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	1
Analyst Price Target Top	$12
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.3
Earnings Revenue Estimate	2,000x
Operating Income	$-12M
Operating margin	-1,034.4
Price target	$9.67
Price Target Change	$693
Price Target Change Top	$884

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	13,731,526%
Float Percent	91.67%
Net Borrowing	-2,223,145
Shares Insiders	0.92%
Shares Institutions	6.9%
Shares Out	14,979,502
Shares Qo Q	1.66%
Shares Yo Y	46.86%
Short Float	4.38%
Short Ratio	4.24
Short Shares	4.01

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-11.7M
Adjusted OCF	-11,510,240
Average Volume	194,148.7x
Bv Per Share	0.05
CAPEX	$-227,947
Ch1m	-42.18
Ch1w	-4.69
Ch1y	-48.85
Ch3m	-46.49
Ch3y	-86.38
Ch5y	-93.4
Ch6m	-32.6
Change	-1.61%
Change From Open	-1.61
Close	1.24
Days Gap	0
Depreciation Amortization	2,013,487
Dollar Volume	89,388.2
Earnings Date	2026-08-14
Earnings Time	amc
EBIT	$-12M
EBITDA	$-9.9M
EPS	$-0.95
F Score	3
FCF	$-10.2M
FCF EV Yield	-146.49x
FCF Per Share	$-0.68
Financing CF	18,315,097
Fiscal Year End	December
Founded	2,015
Investing CF	-227,947
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-14
Last Report Date	2026-03-31
Last Split Date	2024-07-01
Last Split Type	Reverse
Last10k Filing Date	2026-03-26
Ma150	1.94
Ma150ch	-36.95%
Ma20	1.64
Ma20ch	-25.75%
Net CF	8,189,817
Next Earnings Date	2026-08-13
Open	1.24
Optionable	No
Position In Range	16.67
Post Close	1.22
Postmarket Change Percent	-1.7
Postmarket Price	$1.2
Ppne	3,726,827
Pre Close	1.24
Price Date	2026-07-31
Ptbv Ratio	24.9
Relative Volume	0.38x
Revenue	1,157,221x
SBC By Revenue	136.04x
Share Based Comp	1,574,269
Tr6m	-32.6%
Us State	California
Volume	73,269
Z Score	-10.43

Daré Bioscience, Inc. (DARE)

Coverage state: Market snapshot only — no published research

Generate the first DARE analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · DARE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All DARE indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on DARE

Frequently asked questions